Immune Response to Infection with Strongyloides stercoralis in Patients with Infection and Hyperinfection

Applied Health Economics and Health Policy

Volumn 1, Issue 4, 2014, Pages 229-233

  Weatherhead, Jill E ^a   Mejia, Rojelio ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

HIV; HTLV 1; Immunology; Immunosuppression; Strongyloides stercoralis; Strongyloidiasis; Th 2

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HYPERINFECTION; IMMUNE RESPONSE; INFECTION; NONHUMAN; ORGAN TRANSPLANTATION; REVIEW; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TH1 TH2 BALANCE;

EID: 85000416229     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40475-014-0032-9     Document Type: Review

References (18)

1. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49:1411–23.
2. Levi ME, Kumar D, Green M, Ison MG, Kaul D, Michaels MG, et al. Considerations for screening live kidney donors for Endemic infections: A viewpoint on the UNOS policy. Am J Transplant. 2014;14:1003–11.
3. Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis. 2010;23:500–4.
4. Ramanathan R, Nutman TB. Strongyloides stercoralis Infection in the Immunocompromised host. Curr Infect Dis Rep. 2008;10:105–10.
5. Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, et al. Impairment of host immune response against Strongyloides stercoralis by human t cell lymphotropic virus type I infection. Am J Trop Med Hyg. 2006;74(2):246–9.
6. Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised population. Clin Microbiol Rev. 2004;17:208–2017.
7. Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcantara L, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol. 2001;23:503–7.
8. Siegel MO, Simon GL. Is Human Immunodeficiency Virus Infection a Risk Factor for Strongyloides stercoralis Hyperinfection and Dissemination? PLOS NTDS. 2012;6:e1581. An excellent review of strongyloidiasis and HIV, history and host immune response.
9. Karp CL, Auwaerter PG. Coinfection with HIV and Tropical Infectious Disease. II. Helminth, Fungal, Bacterial and Viral pathogens. Clin Infect Dis. 2007;45:1214–20.
10. MMWR. Transmission of Strongyloides stercoralis through transplantation of solid organs – Pennsylvania, 2014. 2013; 62(14):264–266.
11. Iriemenam NC, Sanyaolu OU, Oyibo WA, Fagbenro-Beyioku AF. Strongyloides stercoralis and the immune response. Parasitol Int. 2010;59:9–14.
12. Montes M, Sanchez C, Verdonck K, Lake JE, Gonzalez E, Lopez G, et al. Regulatory T Cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLOS NTDS. 2009;3:e456.
13. Nabha L, Krishnan S, Ramanathan R, Mejia R, Roby G, Sheikh V, et al. Prevalence of Strongyloides stercoralis in an urban US AIDS cohort. Pathog Glob Health. 2012;106:238–44. This research paper addressed the prevalence strongyloidiasis in a US HIV cohort.
14. Le M, Raven K, Hasan A, Clauss H, Muchant DG, Pasko JK, et al. Single Donor Derived Strongyloidiasis in three solid organ transplant recipients: Case series and review of the literature. Am J Transplant. 2014;14:1199–206. An important case series describing risks of strongyloidiasis in solid organ transplant.
15. Salles F, Bacellar A, Amorim M, Orge G, Sundberg M, Lima M, et al. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis co-infected patients is associated with increased TNF alpha and decreased soluble IL2 receptor levels. Trans R Soc Trop Med Hyg. 2013;107:526–9.
16. Mejia R, Nutman TB. Screening, prevention and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis. 2012;25:458–63. A comprehensive clinical review of strongyloidiasis and prevention of dissemination.
17. Krishnamurthy R, Dincer HE, Whittemore D. Strongyloides stercoralis Hyperinfection in a Patient with Rheumatoid Arthritis after anti-TNF-alpha therapy. J Clin Rheumatol. 2007;13:150–2.
18. Ashraf M, Cue C, Badour L. Strongyloidiasis Refractory to treatment with ivermectin. Am J Med Sci. 1996;311:178–9.